Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2016-03-29

Clinical Trial Update: Magnesium Sulphate for Treatment of New Onset Atrial Fibrillation in Medical Intensive Care Unit Patient [NA]

View source ↗

Summary

A Mahidol University trial investigates magnesium sulfate for treating new-onset atrial fibrillation in ICU patients; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium Sulphate (magnesium sulfate)

Snippet

Sponsor: Mahidol University | Conditions: Atrial Fibrillation | NA | Status: UNKNOWN